Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
Posttransplant lymphoproliferative disorder (PTLD) is a frequent complication of intestinal transplantation and is associated with a poor prognosis. There is currently no consensus on optimal therapy. Recurrent PTLD involving the central nervous system (CNS) represents a particularly difficult thera...
Saved in:
| Main Authors: | Clare J. Twist, Ricardo O. Castillo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Case Reports in Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2013/765230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01) -
Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
by: Bharat Malhotra, et al.
Published: (2015-01-01) -
Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder
by: Pierre Isnard, et al.
Published: (2024-03-01) -
Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
by: Sarah E. Halula, et al.
Published: (2015-01-01) -
Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)